Europe's renewable securitisation market is still small enough to count deal by deal. That is exactly why the pricing benchmarks that do exist are worth reading closely before you take a portfolio to trade buyers.
A portfolio sale and a securitisation are not two ways to raise money. One ends your ownership and crystallises a valuation; the other terms out the debt and leaves you holding the equity tail. Choosing between them is a decision about what you want to still own in 2035.
There is no index for European renewable ABS because there is not yet enough of it to index. The market is described deal by deal in trade press. The reference points are few, which makes each one disproportionately important.
Golden Ray 1 (Enpal, Germany) priced on 31 October 2024 at €240m — Europe's first public residential solar securitisation. It remains the most completely disclosed European pricing benchmark in the asset class:
| Tranche | Size | Rating (Moody's / KBRA) | Spread |
|---|---|---|---|
| A1 | €50.0m | Aaa / AAA | 1mE + 80 bp (EIF-guaranteed) |
| A2 | €149.2m | Aa3 / AA− | 1mE + 120 bp |
| B | €12.0m | A2 / A− | 1mE + 225 bp |
| C | €9.6m | Baa3 / BBB | 1mE + 300 bp |
| D | €4.8m | Ba2 / BB+ | 1mE + 450 bp |
| E | €2.4m | B2 / B+ | 1mE + 595 bp |
| F | €12.0m | Not rated | 10.0% fixed |
The pool: 8,469 solar loans, average €28,339, weighted average coupon 5.97%, weighted average remaining term 295 months. Books reached up to 9.5x during bookbuilding, allowing spreads to tighten by more than 50bp and still close 2.5–6.2x covered. Investors split asset managers and real money 55%, banks 23%, official institutions 22%. The EIB invested €50m directly; the EIF guaranteed the A1 tranche outright.
That is the single most useful data point in the European market right now, and it is uncomfortable. Golden Ray 2 (€303m, solar plus heat pump loans, heat pumps 25.8% of the pool) performed well on credit — roughly 0.1% cumulative defaults in year one, an average constant default rate near 1%, mezzanine covered 4-5x. The senior still struggled. Public-institution support, not asset performance, is currently doing the heavy lifting at the top of European renewable ABS capital structures.
US solar ABS has issued roughly $26bn cumulatively since 2013, with $4.3bn in each of 2022 and 2023. Individual deals now routinely exceed the size of Europe's entire public deal history in the asset class: Sunrun priced $886.3m in June 2024 (Class A rated A+, 6.25% coupon, 205bp), and $267m in August 2026 (Class A rated A, 6.28%, 200bp) — its seventeenth securitisation since 2015.
Two implications for a European sponsor. First, a repeat-issuer curve is worth real basis points, and nobody in Europe has one yet. Second, the depth is not there to assume execution: a European renewable ABS is still a bespoke transaction requiring anchor investors, usually including a public institution.
There is no reliable public comparison of the valuation multiples achieved in a European renewable portfolio trade sale against the effective economics of a securitisation of the same assets, nor a published all-in transaction cost comparison, nor a stated minimum viable deal size for a rated European bond versus a private placement. Anyone presenting those as market data is presenting judgement. So are we — the framework above is drawn from transaction experience, not from a published dataset, and should be treated accordingly.
The buyer base for this paper is shaped by regulatory capital. Under Solvency II, qualifying infrastructure treatment reduces the equity risk charge from 49% to 36% for corporate infrastructure and 30% for project infrastructure. On the debt side, the spread sub-module capital cost falls by roughly 30% for corporate infrastructure and 40% for project infrastructure relative to standard corporate debt, subject to the qualifying criteria in Articles 164a and 164b of the Delegated Regulation.
That differential is why insurers will look at a structure they would otherwise price out of. Structuring to qualify is not a compliance exercise — it is a pricing exercise.
The EU Green Bond Standard has applied since 21 December 2024 and explicitly extends to green securitisations. Uptake in its first year exceeded €22bn, with grid and renewable utilities among early adopters. Worth noting: Golden Ray 1 was aligned to the ICMA Green Bond Principles with an ISS Corporate second party opinion, not labelled under EuGBS. Whether the label commands a pricing benefit in this asset class is not yet demonstrated.
European battery storage attracted €6.1bn of disclosed debt in 2025, up from €1.4bn. All of it, as far as public reporting shows, is bank project finance and private credit. We could find no public, rated, BESS-backed securitisation or project bond in Europe as at August 2026.
That is a gap, not a verdict. The obstacles are real — short operating histories, contested revenue forecasting, and revenue structures that vary deal to deal in ways rating methodologies dislike. But the raw material is arriving: 15-year MACSE contracts in Italy, 15-year fixed tolls in the UK, and portfolios reaching the scale where aggregation makes sense. The first sponsor to term out a tolled BESS portfolio in the capital markets will set the benchmark everyone else prices against.
Securitisation moves credit risk. It does not remove it. In June 2025 the US market saw two originator insolvencies in five days: Sunnova's TEP Developer subsidiary filed Chapter 11 on 5 June, and Solar Mosaic — a platform with more than $15bn of home energy loans across roughly 500,000 households — filed on 9 June, emerging on 22 September after restructuring approximately $3.8bn of ABS across 21 series.
Notes largely kept paying. The originators did not survive intact. If you are structuring a European transaction, the servicer replacement mechanics and the back-up servicing arrangements deserve more of your attention than the headline spread.
Transaction figures are as publicly reported and current to August 2026. Rating agency criteria referenced here are described directionally; the agencies' current published methodologies are subscription-gated and should be consulted directly before structuring. This note is market commentary, not legal, regulatory, tax or investment advice, and is not an offer or invitation in respect of any security. It is not a recommendation to buy, sell or hold any instrument.
Send the shape — asset type, jurisdictions, contracted share, aggregate size, remaining tenor, existing debt. A partner responds within two working days on whether a capital markets execution is realistic, and what it would need.